Clinical Trial Update: Trial of AD113 and Atomoxetine in OSA Patients With Hypertension [Phase 2]

View source ↗

Summary

Phase 2 trial of AD113 and atomoxetine in obstructive sleep apnea patients with hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Obstructive Sleep Apnea

Drugs mentioned

• AD113
• Atomoxetine (Atomoxetine)

Snippet

Sponsor: Apnimed | Conditions: Obstructive Sleep Apnea, Hypertension | Phase 2 | Status: COMPLETED